Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000310158-18-000012
Filing Date
2018-05-08
Accepted
2018-05-08 16:41:20
Documents
5
Effectiveness Date
2018-05-08

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS - REMINDER LETTER schedule14a_definitiveaddi.htm DEFA14A 29443
2 mrkifllgrgbtldkgry.jpg GRAPHIC 85832
3 schedule14adefinitive_image1.jpg GRAPHIC 882
4 schedule14adefinitive_image2.jpg GRAPHIC 8006
5 schedule14adefinitive_image3.jpg GRAPHIC 14630
  Complete submission text file 0000310158-18-000012.txt   177681
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-06571 | Film No.: 18815287
SIC: 2834 Pharmaceutical Preparations